Summary
This prediction ended on 08.03.24 with a price of €26.40. Massive losses of -54.12% were the result for the BUY prediction by Midas. Midas has a follow-up prediction for Bayer AG where he still thinks Bayer AG is a Buy. Dividends of €2.55 are taken into consideration when calculating the performance. Midas has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bayer AG | -1.583% | -1.583% | 58.555% | -36.424% |
| iShares Core DAX® | 0,42 % | 5,71 % | 4,70 % | 50,38 % |
| iShares Nasdaq 100 | 4,10 % | 16,64 % | 38,95 % | 104,42 % |
| iShares Nikkei 225® | 4,47 % | 18,34 % | 50,39 % | 74,97 % |
| iShares S&P 500 | 1,79 % | 9,64 % | 26,90 % | 72,28 % |
Comments by Midas for this prediction
In the thread Trading Bayer AG
Die von Midas gewählte maximale Laufzeit wurde überschritten